Ikena Oncology Competitors and Similar CompaniesClear all
Ikena Oncology's competitors and similar companies include Antikor, iBio and EpiPharm.
 Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. |  Antikor Antikor is a biotechnology company that specializes in the discovery and development of small-format antibody-drug conjugates. |  EpiPharm EpiPharm is a biopharmaceutical company developing non-invasive products for the treatment of benign skin tumours and hyperpigmentation disorders. | ||
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 2008 | Founding Date 2007 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Boston, US HQ | Locations Stevenage, GB HQ | Locations San Diego, US HQ Bryan, US | Locations Binningen, CH HQ |
Employees | Employees 5052% increase | Employees 11 | Employees 1630% decrease | Employees 4 |
Valuation ($) | Valuation ($) 82.5 m | Valuation ($) N/A | Valuation ($) 26.2 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $800k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $400k (FY, 2025) | Revenue (est.) N/A |
Funding | ||||
Total funding raised | Total funding raised $ 49m | Total funding raised N/A | Total funding raised $ 9.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Antikor
HQ
Stevenage, GB
Employees
11
Antikor is a biotechnology company that specializes in the discovery and development of small-format antibody-drug conjugates.
View companyEpiPharm
HQ
Binningen, CH
Employees
4
EpiPharm is a biopharmaceutical company developing non-invasive products for the treatment of benign skin tumours and hyperpigmentation disorders.
View company